BCT Press Release
Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

Press Release

Terumo Blood and Cell Technologies to Present at Leading International Event for Regenerative Medicine and Advanced Therapies



Cell & Gene Meeting on the Mesa (Oct 12-16, 2020) is the sector's foremost annual conference to advance cutting-edge research into cures.

LAKEWOOD, COLO., U.S.A. – 9 October 2020 – Colleen Riley, Senior Vice President Innovation and Development and Delara Motlagh, Vice President Cell Therapy Technologies will present at the annual Cell & Gene Meeting on the Mesa to be held virtually October 12-16.


A person smiling for the camera    Description automatically generated

Colleen Riley will share the company's vision and strategy for growth in cell and gene therapy. She'll focus on the company's history of automating and streamlining cell processing from blood centers to therapeutic apheresis and how Terumo Blood and Cell Technologies is bringing the same to complex cell and gene therapy manufacturing. Her presentation is entitled Accelerating the Development of Tomorrow's Therapies Together.


Delara Motlagh has been invited to be a panelist on the session GMP Manufacturing for Cell and Gene Therapies – a 2020 Perspective. The discussion will focus on issues related to moving from development through to GMP manufacturing of cell and gene therapies including challenges, scalability, standards and issues raised in light of COVID-19.

Terumo Blood and Cell Technologies is committed to the advancement of cell and gene therapies and is a proud sponsor of this event.  A team of experts representing Innovation and Development, Corporate Development, Scientific Affairs and Marketing will be available throughout the conference to connect.

About Meeting on the Mesa

Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a five-day virtual conference featuring more than 120 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. The meeting also includes over 100 panelists and featured speakers taking part in 20 in-depth sessions covering all aspects of cell and gene therapy commercialization.

Event:  2020 Virtual Cell & Gene Meeting on the Mesa

Date:   Monday, October 12 – Friday, October 16, 2020
Time:   Company presentations will be available to view on-demand throughout the entirety of the conference
Visit www.meetingonthemesa.com for full information including registration.

About Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies is a medical device company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. TERUMOBCT.COM

Media Contact
Christine Romero, press@terumobct.com

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{$index+1}}. {{s.label}}